BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 18469537)

  • 1. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
    Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
    Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing effect of a Phaseolus vulgaris dry extract on operant self-administration of a chocolate-flavoured beverage in rats.
    Maccioni P; Colombo G; Riva A; Morazzoni P; Bombardelli E; Gessa GL; Carai MA
    Br J Nutr; 2010 Sep; 104(5):624-8. PubMed ID: 20338076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABA
    Maccioni P; Colombo G; Lorrai I; Zaru A; Carai MAM; Gessa GL; Brizzi A; Mugnaini C; Corelli F
    Psychopharmacology (Berl); 2017 Sep; 234(17):2525-2543. PubMed ID: 28536867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of CB1 cannabinoid receptor impairs cocaine self-administration.
    Soria G; Mendizábal V; Touriño C; Robledo P; Ledent C; Parmentier M; Maldonado R; Valverde O
    Neuropsychopharmacology; 2005 Sep; 30(9):1670-80. PubMed ID: 15742004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats.
    Colombo G; Vacca G; Serra S; Carai MA; Gessa GL
    Eur J Pharmacol; 2004 Sep; 498(1-3):119-23. PubMed ID: 15363985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.
    Rasmussen EB; Huskinson SL
    Behav Pharmacol; 2008 Oct; 19(7):735-42. PubMed ID: 18797250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats.
    Zaru A; Maccioni P; Colombo G; Gessa GL
    Br J Nutr; 2013 Oct; 110(8):1524-33. PubMed ID: 23561307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
    Ward SJ; Dykstra LA
    Behav Pharmacol; 2005 Sep; 16(5-6):381-8. PubMed ID: 16148442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
    Wakley AA; Rasmussen EB
    Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
    Forget B; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area.
    Simonnet A; Cador M; Caille S
    Addict Biol; 2013 Nov; 18(6):930-6. PubMed ID: 22784230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
    Niyuhire F; Varvel SA; Thorpe AJ; Stokes RJ; Wiley JL; Lichtman AH
    Psychopharmacology (Berl); 2007 Apr; 191(2):223-31. PubMed ID: 17211653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats.
    Gessa GL; Serra S; Vacca G; Carai MA; Colombo G
    Alcohol Alcohol; 2005; 40(1):46-53. PubMed ID: 15582988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.